Stockreport

Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Therapeutics, Inc.  (CMPX) 
PDF BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietar [Read more]